Mettler-Toledo Debt to Equity Ratio 2010-2024 | MTD
Current and historical debt to equity ratio values for Mettler-Toledo (MTD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Mettler-Toledo debt/equity for the three months ending December 31, 2024 was 0.00.
| Mettler-Toledo Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $3.37B | $-0.13B | -26.53 |
| 2024-09-30 | $3.47B | $-0.15B | -22.51 |
| 2024-06-30 | $3.40B | $-0.15B | -22.27 |
| 2024-03-31 | $3.44B | $-0.16B | -21.69 |
| 2023-12-31 | $3.51B | $-0.15B | -23.38 |
| 2023-09-30 | $3.40B | $-0.11B | -32.06 |
| 2023-06-30 | $3.46B | $-0.09B | -38.57 |
| 2023-03-31 | $3.43B | $-0.02B | -140.36 |
| 2022-12-31 | $3.47B | $0.03B | 139.86 |
| 2022-09-30 | $3.38B | $-0.08B | -40.78 |
| 2022-06-30 | $3.33B | $0.01B | 458.44 |
| 2022-03-31 | $3.27B | $0.09B | 38.69 |
| 2021-12-31 | $3.16B | $0.17B | 18.41 |
| 2021-09-30 | $3.05B | $0.16B | 19.15 |
| 2021-06-30 | $2.95B | $0.19B | 15.42 |
| 2021-03-31 | $2.83B | $0.20B | 13.94 |
| 2020-12-31 | $2.53B | $0.28B | 8.96 |
| 2020-09-30 | $2.32B | $0.44B | 5.24 |
| 2020-06-30 | $2.23B | $0.45B | 4.95 |
| 2020-03-31 | $2.58B | $0.31B | 8.42 |
| 2019-12-31 | $2.37B | $0.42B | 5.63 |
| 2019-09-30 | $2.20B | $0.44B | 5.01 |
| 2019-06-30 | $2.16B | $0.50B | 4.28 |
| 2019-03-31 | $2.08B | $0.56B | 3.69 |
| 2018-12-31 | $2.03B | $0.59B | 3.44 |
| 2018-09-30 | $2.03B | $0.53B | 3.81 |
| 2018-06-30 | $2.03B | $0.53B | 3.81 |
| 2018-03-31 | $1.95B | $0.56B | 3.48 |
| 2017-12-31 | $2.00B | $0.55B | 3.66 |
| 2017-09-30 | $1.98B | $0.51B | 3.87 |
| 2017-06-30 | $1.79B | $0.46B | 3.87 |
| 2017-03-31 | $1.76B | $0.44B | 4.01 |
| 2016-12-31 | $1.73B | $0.44B | 3.98 |
| 2016-09-30 | $1.72B | $0.50B | 3.44 |
| 2016-06-30 | $1.57B | $0.49B | 3.19 |
| 2016-03-31 | $1.49B | $0.54B | 2.75 |
| 2015-12-31 | $1.38B | $0.58B | 2.38 |
| 2015-09-30 | $1.47B | $0.59B | 2.50 |
| 2015-06-30 | $1.44B | $0.65B | 2.21 |
| 2015-03-31 | $1.31B | $0.67B | 1.97 |
| 2014-12-31 | $1.29B | $0.72B | 1.79 |
| 2014-09-30 | $1.26B | $0.85B | 1.48 |
| 2014-06-30 | $1.24B | $0.91B | 1.36 |
| 2014-03-31 | $1.21B | $0.92B | 1.31 |
| 2013-12-31 | $1.22B | $0.94B | 1.30 |
| 2013-09-30 | $1.30B | $0.85B | 1.53 |
| 2013-06-30 | $1.32B | $0.81B | 1.63 |
| 2013-03-31 | $1.27B | $0.80B | 1.59 |
| 2012-12-31 | $1.20B | $0.83B | 1.45 |
| 2012-09-30 | $1.26B | $0.80B | 1.58 |
| 2012-06-30 | $1.28B | $0.78B | 1.65 |
| 2012-03-31 | $1.31B | $0.81B | 1.62 |
| 2011-12-31 | $1.42B | $0.78B | 1.82 |
| 2011-09-30 | $1.48B | $0.82B | 1.80 |
| 2011-06-30 | $1.50B | $0.84B | 1.79 |
| 2011-03-31 | $1.51B | $0.79B | 1.91 |
| 2010-12-31 | $1.51B | $0.77B | 1.96 |
| 2010-09-30 | $1.15B | $0.76B | 1.53 |
| 2010-06-30 | $1.03B | $0.72B | 1.43 |
| 2010-03-31 | $1.00B | $0.71B | 1.41 |
| 2009-12-31 | $1.01B | $0.71B | 1.42 |
| 2009-09-30 | $1.03B | $0.65B | 1.58 |
| 2009-06-30 | $1.07B | $0.59B | 1.80 |
| 2009-03-31 | $1.10B | $0.52B | 2.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.400B | $3.872B |
| Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |